Orchestra Biomed Holdings Inc (OBIO)

Jun 18, 2025

Orchestra BioMed Showcases AVIM Therapy as Purpose-Built - GlobeNewswire

Jun 18, 2025

Jun 14, 2025

Millennium Management LLC Makes New Investment in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World

Jun 14, 2025

Jun 12, 2025

Citadel Advisors LLC Sells 7,836 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World

Jun 12, 2025

Jun 11, 2025

(OBIO) Trading Advice - news.stocktradersdaily.com

Jun 11, 2025

Jun 02, 2025

Orchestra Biomed Reports Increased Losses Amid Revenue Growth - TipRanks

Jun 02, 2025

May 30, 2025

B. Riley Cuts Price Target on Orchestra BioMed Holdings to $12 From $15, Keeps Buy Rating - marketscreener.com

May 30, 2025

May 30, 2025

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Stake Increased by Northern Trust Corp - Defense World

May 30, 2025

May 28, 2025

Orchestra BioMed: Two Best-In-Class Devices And Promising Partnerships - Seeking Alpha

May 28, 2025

May 21, 2025

Orchestra BioMed Reports Q1 2025 Financial Results and Advances Key Clinical Programs - MSN

May 21, 2025

May 19, 2025

How To Trade (OBIO) - news.stocktradersdaily.com

May 19, 2025

May 19, 2025

The Manufacturers Life Insurance Company Raises Position in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World

May 19, 2025

May 18, 2025

FY2026 Earnings Estimate for OBIO Issued By Chardan Capital - Defense World

May 18, 2025

May 15, 2025

Orchestra BioMed Expands Patent Portfolio for AVIM Therapy, Gains FDA Breakthrough Designation - MSN

May 15, 2025

May 14, 2025

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 14, 2025

May 14, 2025

Chardan Capital Maintains Buy Rating on OBIO with $20 Price Targ - GuruFocus

May 14, 2025

May 14, 2025

Barclays PLC Boosts Holdings in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World

May 14, 2025

May 14, 2025

Wells Fargo & Company MN Buys 3,992 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World

May 14, 2025

May 14, 2025

Orchestra BioMed HoldingsBreakthrough Device Designation Gives Speculative Optimism - Seeking Alpha

May 14, 2025

May 13, 2025

Chardan Capital Maintains Buy Rating on OBIO with $20 Price Target | OBIO Stock News - GuruFocus

May 13, 2025

May 13, 2025

Orchestra BioMed (OBIO) Surpasses Revenue Estimates with Strong Q1 Growth | OBIO Stock News - GuruFocus

May 13, 2025

May 12, 2025

Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones - The Manila Times

May 12, 2025

May 12, 2025

Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy and IDE Approval for Virtue SAB Trial - Nasdaq

May 12, 2025

May 12, 2025

Orchestra BioMed Reports First Quarter 2025 Financial - GlobeNewswire

May 12, 2025

May 09, 2025

4 No-Brainer Stocks to Buy Right Now - The Globe and Mail

May 09, 2025

May 09, 2025

(OBIO) On The My Stocks Page - news.stocktradersdaily.com

May 09, 2025

May 08, 2025

Orchestra BioMed receives FDA approval to initiate Virtue Trial - Med-Tech Insights

May 08, 2025

May 08, 2025

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Shares Sold by Price T Rowe Associates Inc. MD - The AM Reporter

May 08, 2025

May 08, 2025

RTW INVESTMENTS, LP Increases Stake in Orchestra BioMed Holdings Inc - GuruFocus

May 08, 2025

May 07, 2025

ORCHESTRA BIOMED Earnings Preview: Recent $OBIO Insider Trading, Hedge Fund Activity, and More - Nasdaq

May 07, 2025

May 07, 2025

Orchestra BioMed’s AVIM Therapy Global Intellectual - GlobeNewswire

May 07, 2025

May 07, 2025

Orchestra BioMed (OBIO) Expands Patent Portfolio for AVIM Therap - GuruFocus

May 07, 2025

May 07, 2025

Orchestra BioMed Expands Patent Portfolio with 10 New Patents for Hypertension Treatment, Totaling 120 Global Patents - Nasdaq

May 07, 2025

May 07, 2025

Orchestra BioMed’s AVIM Therapy Global Intellectual Property Estate Reaches 137 Issued Patents for the Treatment of Hypertension and Heart Failure - GlobeNewswire

May 07, 2025

May 07, 2025

Orchestra BioMed Holdings, Inc. (OBIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - MSN

May 07, 2025

May 06, 2025

BlackRock, Inc. Reduces Stake in Orchestra BioMed Holdings Inc. - GuruFocus

May 06, 2025

May 06, 2025

Orchestra BioMed (NASDAQ:OBIO) Price Target Lowered to $12.00 at Barclays - Defense World

May 06, 2025

May 06, 2025

Orchestra BioMed Holdings (OBIO) Target Price Adjustment by Barc - GuruFocus

May 06, 2025

May 05, 2025

Barclays Adjusts Price Target for Orchestra BioMed (OBIO) | OBIO Stock News - GuruFocus

May 05, 2025

May 04, 2025

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Shares Bought by JPMorgan Chase & Co. - Defense World

May 04, 2025

May 01, 2025

OBIO: Riding the Market Waves of Growth and Decline in 2023 - investchronicle.com

May 01, 2025

May 01, 2025

How did Orchestra BioMed Holdings Inc (OBIO) fare last session? - uspostnews.com

May 01, 2025

May 01, 2025

Orchestra BioMed Secures FDA Clearance for Virtue Trial to Advance Coronary ISR Treatment - MyChesCo

May 01, 2025

May 01, 2025

Orchestra Biomed sees $149,201 stock purchase by RTW Investments By Investing.com - Investing.com Australia

May 01, 2025

May 01, 2025

Orchestra BioMed Holdings Inc [OBIO] Records 200-Day SMA of $5.25 - knoxdaily.com

May 01, 2025

May 01, 2025

Orchestra BioMed to Present at Jefferies Global Healthcare Conference - MyChesCo

May 01, 2025